1. Home
  2. VALN vs AMN Comparison

VALN vs AMN Comparison

Compare VALN & AMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • AMN
  • Stock Information
  • Founded
  • VALN 2012
  • AMN 1985
  • Country
  • VALN France
  • AMN United States
  • Employees
  • VALN N/A
  • AMN N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • AMN Assisted Living Services
  • Sector
  • VALN Health Care
  • AMN Health Care
  • Exchange
  • VALN Nasdaq
  • AMN Nasdaq
  • Market Cap
  • VALN 669.2M
  • AMN 710.9M
  • IPO Year
  • VALN 2021
  • AMN 2001
  • Fundamental
  • Price
  • VALN $9.11
  • AMN $17.25
  • Analyst Decision
  • VALN Strong Buy
  • AMN Hold
  • Analyst Count
  • VALN 3
  • AMN 8
  • Target Price
  • VALN $15.33
  • AMN $31.92
  • AVG Volume (30 Days)
  • VALN 65.5K
  • AMN 862.6K
  • Earning Date
  • VALN 08-12-2025
  • AMN 08-07-2025
  • Dividend Yield
  • VALN N/A
  • AMN N/A
  • EPS Growth
  • VALN N/A
  • AMN N/A
  • EPS
  • VALN N/A
  • AMN N/A
  • Revenue
  • VALN $201,099,222.00
  • AMN $2,769,926,000.00
  • Revenue This Year
  • VALN $18.61
  • AMN N/A
  • Revenue Next Year
  • VALN $25.07
  • AMN $1.95
  • P/E Ratio
  • VALN N/A
  • AMN N/A
  • Revenue Growth
  • VALN 21.64
  • AMN N/A
  • 52 Week Low
  • VALN $3.62
  • AMN $14.87
  • 52 Week High
  • VALN $9.10
  • AMN $62.43
  • Technical
  • Relative Strength Index (RSI)
  • VALN 80.93
  • AMN 33.66
  • Support Level
  • VALN $7.15
  • AMN $17.36
  • Resistance Level
  • VALN $7.82
  • AMN $17.76
  • Average True Range (ATR)
  • VALN 0.40
  • AMN 0.88
  • MACD
  • VALN 0.14
  • AMN -0.20
  • Stochastic Oscillator
  • VALN 99.37
  • AMN 41.95

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About AMN AMN Healthcare Services Inc

AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are; nurse and allied solutions, physician and leadership solutions, and technology and workforce solutions. A majority of its revenue is generated from the nurse and allied solutions segment which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.

Share on Social Networks: